mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |